About
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com
Tags
Total Employees
10
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
30Traction
10Team
0Visibility
20Profile
60Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Galmed Pharmaceuticals do?
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, ple…
When was Galmed Pharmaceuticals founded?
Galmed Pharmaceuticals was founded in 2000.
What industry does Galmed Pharmaceuticals operate in?
Galmed Pharmaceuticals operates in Life Sciences.
How many employees does Galmed Pharmaceuticals have?
Galmed Pharmaceuticals has approximately 10 people on record.
What is Galmed Pharmaceuticals's current status?
Galmed Pharmaceuticals's current operating status is: Public.